Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 661

1.

Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.

Devlin A, Waikar SS, Solomon DH, Lu B, Shaykevich T, Alarcón GS, Winkelmayer WC, Costenbader KH.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1642-53. doi: 10.1002/acr.20607.

2.

Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Drenkard C, Patzer RE, Klein M, Kramer MR, Pastan S, Lim SS, McClellan WM.

Arthritis Rheumatol. 2015 Mar;67(3):761-72. doi: 10.1002/art.38983.

3.

Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

Costenbader KH, Desai A, Alarcón GS, Hiraki LT, Shaykevich T, Brookhart MA, Massarotti E, Lu B, Solomon DH, Winkelmayer WC.

Arthritis Rheum. 2011 Jun;63(6):1681-8. doi: 10.1002/art.30293.

4.

Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.

Nee R, Martinez-Osorio J, Yuan CM, Little DJ, Watson MA, Agodoa L, Abbott KC.

Am J Kidney Dis. 2015 Oct;66(4):630-7. doi: 10.1053/j.ajkd.2015.04.011. Epub 2015 May 19.

PMID:
26002293
5.

End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.

Hiraki LT, Lu B, Alexander SR, Shaykevich T, Alarcón GS, Solomon DH, Winkelmayer WC, Costenbader KH.

Arthritis Rheum. 2011 Jul;63(7):1988-97. doi: 10.1002/art.30350.

6.

Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.

Plantinga LC, Patzer RE, Drenkard C, Pastan SO, Cobb J, McClellan W, Lim SS.

BMC Nephrol. 2015 Mar 29;16:39. doi: 10.1186/s12882-015-0037-1.

7.

Disparities among Blacks, Hispanics, and Whites in time from starting dialysis to kidney transplant waitlisting.

Joshi S, Gaynor JJ, Bayers S, Guerra G, Eldefrawy A, Chediak Z, Companioni L, Sageshima J, Chen L, Kupin W, Roth D, Mattiazzi A, Burke GW 3rd, Ciancio G.

Transplantation. 2013 Jan 27;95(2):309-18. doi: 10.1097/TP.0b013e31827191d4.

PMID:
23325005
8.

[REIN Report 2011--summary].

Couchoud C, Lassalle M, Jacquelinet C.

Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1. French.

PMID:
24119584
9.

Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis.

Gómez-Puerta JA, Feldman CH, Alarcón GS, Guan H, Winkelmayer WC, Costenbader KH.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1453-62. doi: 10.1002/acr.22562.

10.

[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].

Antonucci F, Camerin E, Feriani M, Nordio M, Piccoli A, Rossi B, Tessitore N.

G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56. Italian.

PMID:
19927265
11.

Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis.

Moon SJ, Park HS, Kwok SK, Ju JH, Kim HY, Park SH.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1):31-9. Epub 2012 Aug 30.

PMID:
22935632
12.

Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease.

Gómez-Puerta JA, Waikar SS, Solomon DH, Liu J, Alarcón GS, Winkelmayer WC, Costenbader KH.

J Clin Cell Immunol. 2013 Dec 1;4(6):179.

13.

Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.

Portolés J, Moreno F, López-Sánchez P, Mancha J, Gómez M, Corchete E, Del Peso G, Bajo MA, Llópez-Carratalá R, Fernández-Perpén A; Grupo Centro Diálisis Peritoneal-GCDP, REDinREN.

Nefrologia. 2011;31(4):441-8. doi: 10.3265/Nefrologia.pre2011.May.10898. English, Spanish.

14.

The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival.

Goldfarb-Rumyantzev AS, Hurdle JF, Scandling JD, Baird BC, Cheung AK.

Am J Kidney Dis. 2005 Sep;46(3):537-49.

PMID:
16129217
15.

Allocation of initial modality for renal replacement therapy in Brazil.

Andrade MV, Junoy JP, Andrade EI, Acurcio Fde A, Sesso R, Queiroz OV, Szuster DA, Gomes IC, Almeida AM, Cherchiglia ML.

Clin J Am Soc Nephrol. 2010 Apr;5(4):637-44. doi: 10.2215/CJN.04840709. Epub 2010 Feb 18.

16.

Disparities in renal replacement in lupus nephritis: current practice and future implications.

Ishimori ML, Gudsoorkar V, Venuturupalli SR, Weisman MH.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1639-41. doi: 10.1002/acr.20611. No abstract available.

17.

Patient characteristics and outcomes by GN subtype in ESRD.

O'Shaughnessy MM, Montez-Rath ME, Lafayette RA, Winkelmayer WC.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1170-8. doi: 10.2215/CJN.11261114. Epub 2015 Jun 19.

18.

ESKD, Transplantation, and Dialysis in Lupus Nephritis.

Sabucedo AJ, Contreras G.

Semin Nephrol. 2015 Sep;35(5):500-8. doi: 10.1016/j.semnephrol.2015.08.011. Review.

PMID:
26573552
19.

ESRD from lupus nephritis in the United States, 1995-2010.

Sexton DJ, Reule S, Solid C, Chen SC, Collins AJ, Foley RN.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):251-9. doi: 10.2215/CJN.02350314. Epub 2014 Dec 22.

20.

Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.

Vidal E, van Stralen KJ, Chesnaye NC, Bonthuis M, Holmberg C, Zurowska A, Trivelli A, Da Silva JEE, Herthelius M, Adams B, Bjerre A, Jankauskiene A, Miteva P, Emirova K, Bayazit AK, Mache CJ, Sánchez-Moreno A, Harambat J, Groothoff JW, Jager KJ, Schaefer F, Verrina E; ESPN/ERA-EDTA Registry.

Am J Kidney Dis. 2017 May;69(5):617-625. doi: 10.1053/j.ajkd.2016.09.024. Epub 2016 Dec 10.

PMID:
27955924

Supplemental Content

Support Center